摘要
目的对头孢噻肟钠舒巴坦钠应用于老年呼吸道感染治疗中的有效性及安全性进行评价。方法 66例老年呼吸道感染患者,将其随机分为实验组和对照组,各33例。实验组给予头孢噻肟钠舒巴坦钠治疗,对照组给予阿奇霉素治疗,比较两组患者的治疗有效性与安全性。结果实验组总有效率为93.94%,高于对照组的75.76%,差异有统计学意义(P<0.05);实验组不良反应发生率为9.09%,低于对照组的30.30%,差异有统计学意义(P<0.05)。结论采用头孢噻肟钠舒巴坦钠治疗老年呼吸道感染,可有效控制感染症状,且不良反应少,有效性、安全性高,值得推广应用。
Objective To evaluate effectiveness and safety by cefotaxime sodium and sulbactam sodium in the treatment of senile respiratory tract infection. Methods A total of 66 senile patients with respiratory tract infection were randomly divided into experimental group and control group, with 33 cases in each group. The experimental group received cefotaxime sodium and sulbactam sodium for treatment, and the control group received azithromycin for treatment. Comparison was made on effectiveness and safety of treatment between the two groups. Results The experimental group had higher total effective rate as 93.94% than 75.76% of the control group, and the difference had statistical significance（P〈0.05）. The experimental group had incidence of adverse reactions as 9.09%, which was lower than 30.30% of the control group, and the difference had statistical significance（P〈0.05）. Conclusion Implement of cefotaxime sodium and sulbactam sodium in treating senile respiratory tract infection can effectively control infection symptom, with few adverse reactions, high effectiveness and safety. It is worth promoting and applying.
作者
赵银英
ZHAO Yin-ying(Guangzhou City Nansha District Lanhe Hospital, Guangzhou 511480, China)
出处
《中国实用医药》
2016年第30期23-24,共2页
China Practical Medicine
关键词
老年呼吸道感染
头孢噻肟钠舒巴坦钠
有效性
安全性
Senile respiratory tract infection
Cefotaxime sodium and sulbactam sodium
Effectiveness
Safety
